Acquisitions - Schedule Of Business Combination, Intangible Asset, Acquired (Details) - Akoya Biosciences, Inc. - USD ($) $ in Thousands |
3 Months Ended | |
|---|---|---|
Jul. 08, 2025 |
Mar. 31, 2026 |
|
| Business Combination [Line Items] | ||
| Definite-lived intangible assets: | $ 102,500 | |
| Weighted Average Useful Life (in years) | 9 years 7 months 6 days | |
| Indefinite-lived intangible assets: | $ 121,800 | |
| In Process Research and Development | ||
| Business Combination [Line Items] | ||
| Indefinite-lived intangible assets: | $ 19,300 | |
| Developed technology | ||
| Business Combination [Line Items] | ||
| Definite-lived intangible assets: | $ 99,600 | |
| Weighted Average Useful Life (in years) | 9 years 7 months 6 days | |
| Customer relationships | ||
| Business Combination [Line Items] | ||
| Definite-lived intangible assets: | $ 2,900 | |
| Weighted Average Useful Life (in years) | 9 years 2 months 12 days |
| X | ||||||||||
- Definition Weighted average amortization period of finite-lived intangible assets acquired either individually or as part of a group of assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of increase in assets, excluding financial assets, lacking physical substance with a definite life, from an acquisition. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of increase in assets, excluding financial assets and goodwill, lacking physical substance with an indefinite life, from an acquisition. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|